Japan’s Astellas Pharma said it agreed to buy U.S. drugmaker Iveric Bio Inc for about $5.9 billion in its biggest acquisition, giving it access to a range of ophthalmology treatments. The deal marks the fifth...
China’s Fosun drops plan to sell stake in Indian drugmaker Gland Pharma – ET Now
China’s Shanghai Fosun Pharmaceutical Group Co Ltd has withdrawn plans to sell stake in Indian drugmaker Gland Pharma Ltd, ET Now tweeted on Wednesday, citing sources. Fosun Pharma holds a 57.86% stake in the...
Ipca Labs set to acquire Unichem promoter’s stake for over ₹ 1,034 cr
lpca Laboratories on Monday said it has entered into a definitive share purchase agreement to acquire Unichem Laboratories promoter’s stake for ₹1,034.06 crore in an all cash deal. lpca will acquire 2,35,01,440...
CCI clears Berhyanda’s acquisition of Suven Pharma
The Competition Commission of India (CCI) has approved Berhyanda Ltd’s acquisition of up to 76.10% in Suven Pharmaceuticals. The acquisition is “by way of a share purchase agreement of December 26, 2022 and pursuant to...
NCLT OKs resolution plan worth ₹250 crore for Unimark Remedies
The National Company Law Tribunal in its order approved the resolution plan for Unimark Remedies, which was submitted by a consortium of Asset Reconstruction Company (India), Intas Pharmaceutical and Shamrock...
Bankruptcy court approves Intas-Shamrock plan for Unimark Remedies
A bankruptcy court on Monday allowed the Intas Pharmaceuticals-Shamrock Pharmachemi consortium’s application to acquire Unimark Remedies. Asset Reconstruction Company India Ltd (Arcil) is also part of the consortium...
EQT in talks for a possible $5.80 billion offer for Dechra
Dechra, a British veterinary pharmaceuticals maker, said it had entered into talks with private equity group EQT for a possible offer in a 4.63 billion pounds ($5.80 billion) all-cash deal. Dechra shareholders would...
Glenmark weighs sale of API business to pare debt
Glenmark Pharmaceuticals Ltd is considering selling a majority stake in Glenmark Life Sciences to pare debt, said two people familiar with the development. Kotak Mahindra Capital Co. Ltd has been hired to run the sale...
Nirma Group acquires eye drop maker Stericon Pharma
The Nirma Group has acquired Bengaluru-based Stericon Pharma Pvt Ltd, a maker of eye drops and contact lens solutions. The financial details were not disclosed, but a statement on the private equity (PE) firm...
Jounce dumps Redx Pharma for acquisition by Concentra; to cut 84% of jobs
Jounce Therapeutics Inc agreed to be acquired by privately held Concentra Biosciences for $96.46 million while spurning a merger deal with British biotech firm Redx Pharma. The new Concentra deal also involves a...
Sun Pharma acquires 60% stake in Vivaldis Health & Foods for ₹143 cr
Drug major Sun Pharmaceutical on Friday announced that it is set to acquire 60 per cent shareholding in Vivaldis Health & Foods for ₹143.30 crore from its existing shareholders, The remaining 40 per cent...
Eris Lifesciences acquires 9 dermatology brands from Dr Reddy’s for Rs 275 cr
Eris Lifesciences on Thursday said it has acquired nine dermatology brands from Dr Reddy’s Laboratories for Rs 275 crore. The acquired brands are largely in cosmetology segments like anti-acne, moisturisers...
